Since tumor microenvironment contains not only CD8 + TILs but also immunosuppressive cells, these findings suggest that unraveling distinct tumor-immune microenvironment features of EGFR-mutant lung cancer41 might be helpful to identify the benefit population. Here, CD8A is linked to neoplasm.